Medscape Medical News - FDA Approvals
- Alert FDA OKs Subcutaneous Vedolizumab for UC Maintenance Therapy
- Alert FDA Approves Bosutinib for Children With CML
- Alert Empagliflozin Gets FDA Nod for CKD Without T2D or HF
- Alert FDA Updates Indications for Temozolomide
- Alert FDA OKs LimFlow for Serious PAD, Reroutes Blood Via Veins
- Alert FDA OKs Motixafortide for Stem Cell Mobilization in Myeloma
- FDA Approves Canakinumab for Gout Flares
- Alert FDA Clears New Capabilities for Diabetes App BlueStar
- Alert FDA Okays First Biosimilar for Multiple Sclerosis
- Alert FDA Approves First RSV Vaccine for Pregnancy
- FDA Approves Elranatamab for Multiple Myeloma
- Alert FDA OKs Talquetamab, a First-in-Class Multiple Myeloma Drug
- Alert FDA OKs Dostarlimab Plus Chemo for Endometrial Cancer
- Alert FDA Approves Second OTC Naloxone Spray for Opioid Overdose
- Alert FDA Approves Quizartinib for Newly Diagnosed AML
- Alert FDA Approves RSV Injection for All Infants
- Alert FDA Clears the Tandem Mobi Insulin Pump
- Alert FDA Approves New Device for Enlarged Prostate Treatment
- Alert FDA Approves Cognitive-Behavioral App for Adults With T2D
- Alert FDA OKs Inclisiran, Added to Statins, for Primary Prevention